Skip to content
BIO 2025: What is the PRV program and why does it matter?
Established in 2012, the Pediatric Priority Review (PPRV) program offers a powerful incentive ...
Read More
BIO 2025: Health equity as an engine for scalable innovation
Health equity should not be considered a parallel initiative, but a central pillar ...
Read More
BIO 2025: ‘Behind every data point there is a person’
The 2025 Biotechnology Innovation Organization (BIO) International Convention highlighted why we – the ...
Read More
BIO 2025: Rare disease patients can’t wait
The rare disease patient community is the beating heart of the Biotechnology Innovation ...
Read More
Biotech and national security: ‘Time to act but no time to wait’
The threat to America’s leadership in biotech is a threat to our national ...
Read More
BIO 2025: A few highlights from Day 2
George W. Bush, 43rd President of the United States, headlined Tuesday’s mainstage with ...
Read More
EDITORS' CHOICE
Pennsylvania’s Gov. Shapiro courts biotechs at BIO 2025
Pennsylvania is open for biotech business and working hard to grow the life sciences ecosystem that already exists in the state, according to Gov. Josh ...
Read More
LATEST NEWS
BIO Events
BIO 2025: What is the PRV program and why does it matter?
Established in 2012, the Pediatric Priority Review (PPRV) program offers a powerful incentive for companies to develop treatments for rare conditions affecting children. Even though ...
BIO Events
BIO 2025: Health equity as an engine for scalable innovation
Health equity should not be considered a parallel initiative, but a central pillar of the biotech industry’s strategy, said experts on Day 3 of the ...
BIO Events
BIO 2025: ‘Behind every data point there is a person’
The 2025 Biotechnology Innovation Organization (BIO) International Convention highlighted why we – the biotech industry – do what we do. In one word: patients. On ...
BIO Events
BIO 2025: Rare disease patients can’t wait
The rare disease patient community is the beating heart of the Biotechnology Innovation Organization’s (BIO) mission. Whether it is driving policy that supports innovation, improving ...
BIO Events
Biotech and national security: ‘Time to act but no time to wait’
The threat to America’s leadership in biotech is a threat to our national security that we need to address now, two members of a congressional ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
Climate Change
Combatting misinformation on biotechnology in food
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand ...
Read More
Federal Policy
State Policy
BIO 2025: A few highlights from Day 2
George W. Bush, 43rd President of the United States, headlined Tuesday’s mainstage with an exclusive conversation with Biotechnology Innovation Organization ...
Read More
International
Bio's View
BIO 2025: Rare disease patients can’t wait
The rare disease patient community is the beating heart of the Biotechnology Innovation Organization’s (BIO) mission. Whether it is driving ...
Read More
